Development of a Microsimulation Model to Project the Future Prevalence of Childhood Cancer in Ontario, Canada

Alexandra Moskalewicz, Sumit Gupta, Paul C. Nathan and Petros Pechlivanoglou
Additional contact information
Alexandra Moskalewicz: The Hospital for Sick Children Research Institute, Child Health Evaluative Sciences program, Toronto, ON, Canada
Sumit Gupta: The Hospital for Sick Children Research Institute, Child Health Evaluative Sciences program, Toronto, ON, Canada
Paul C. Nathan: The Hospital for Sick Children Research Institute, Child Health Evaluative Sciences program, Toronto, ON, Canada
Petros Pechlivanoglou: The Hospital for Sick Children Research Institute, Child Health Evaluative Sciences program, Toronto, ON, Canada

Medical Decision Making, 2025, vol. 45, issue 3, 245-256

Abstract: Background Estimates of the future prevalence of childhood cancer are informative for health system planning but are underutilized. We describe the development of a pediatric oncology microsimulation model for prevalence (POSIM-Prev) and illustrate its application to produce projections of incidence, survival, and limited-duration prevalence of childhood cancer in Ontario, Canada, until 2040. Methods POSIM-Prev is a population-based, open-cohort, discrete-time microsimulation model. The model population was updated annually from 1970 to 2040 to account for births, deaths, net migration, and incident cases of childhood cancer. Prevalent individuals were followed until death, emigration, or the last year of simulation. Median population-based outcomes with 95% credible intervals (CrIs) were generated using Monte Carlo simulation. The methodology to derive model inputs included generalized additive modeling of cancer incidence, parametric survival modeling, and stochastic population forecasting. Individual-level data from provincial cancer registries for years 1970 to 2019 informed cancer-related model inputs and internal validation. Results The number of children (aged 0–14 y) diagnosed with cancer in Ontario is projected to rise from 414 (95% CrI: 353–486) in 2020 to 561 (95% CrI: 481–653) in 2039. The 5-y overall survival rate for 2030–2034 is estimated to reach 90% (95% CrI: 88%–92%). By 2040, 24,088 (95% CrI: 22,764–25,648) individuals with a history of childhood cancer (diagnosed in Ontario or elsewhere) are projected to reside in the province. The model accurately reproduced historical trends in incidence, survival, and prevalence when validated. Conclusions The rising incidence and prevalence of childhood cancer will create increased demand for both acute cancer care and long-term follow-up services in Ontario. The POSIM-Prev model can be used to support long-range health system planning and future health technology assessments in jurisdictions that have access to similar model inputs. Highlights This article describes the development of a population-based, discrete-time microsimulation model that can simulate incident and prevalent cases of childhood cancer in Ontario, Canada, until 2040. Use of an open cohort framework allowed for estimation of the potential impact of net migration on childhood cancer prevalence. In addition to supporting long-term health system planning, this model can be used in future health technology assessments, by providing a demographic profile of incident and prevalent cases for model conceptualization and budget impact purposes. This modeling framework is adaptable to other jurisdictions and disease areas where individual-level data for incidence and survival are available.

Keywords: cancer incidence; cancer prevalence; health system planning; microsimulation; pediatric cancer (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X251314031 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:45:y:2025:i:3:p:245-256

DOI: 10.1177/0272989X251314031

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().